Covidien Acquires CNS Therapeutics for $100,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4f5ba081-416d-47f5-8fae-955ebcbb6268&Preview=1 -
Date
9/25/2012 -
Company Name
CNS Therapeutics -
Mailing Address
332 Minnesota Street Saint Paul, MN 55101 -
Company Description
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics. -
Website
http://www.gablofen.com -
Transaction Type
M&A -
Transaction Amount
$100,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Additional financial terms of the transaction were not disclosed by the parties.
